Overall, the trial demonstrated that once-weekly Cagrilintide induced clinically meaningful, dose-dependent weight loss in adults with overweight or obesity, with efficacy comparable or superior to liraglutide 3.0 mg
FOXO4-DRI Safety and Side Effects: What the Evidence Shows (2026) In the published mouse studies, FOXO4-DRI caused no reported side effects: treated animals kept their weight, blood counts, and organ markers while senescent cells were cleared, and the peptide spared healthy cells in culture
People with underlying comorbidities and elderly populations seem to be at heightened risk and more susceptible to infection, including other complications 13,14
The nutrients in our Cold & Flu Drip, including Vitamin C, have been shown to support immune function and overall wellness